Browse by author
Lookup NU author(s): Professor Andrew GenneryORCiD, Professor Andrew Cant
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The molecular bases of most primary immunodeficiencies (PID) have been discovered. Long-term follow-up of patient cohorts treated with antimicrobial prophylaxis has demonstrated good short-term prognosis but with increasing morbidity and mortality over time. The results of hematopoietic stem cell transplantation (HSCT) for PID have improved incrementally over time, with survival and cure of 90% for some defined diseases. This article examines the advances in HSCT for PID and argues that HSCT should be considered earlier for most patients. © 2008 Elsevier Inc. All rights reserved.
Author(s): Gennery AR, Cant AJ
Publication type: Article
Publication status: Published
Journal: Immunology and Allergy Clinics of North America
Year: 2008
Volume: 28
Issue: 2
Pages: 439-456
ISSN (print): 0889-8561
ISSN (electronic): 1557-8607
Publisher: W.B. Saunders Co.
URL: http://dx.doi.org/10.1016/j.iac.2008.01.006
DOI: 10.1016/j.iac.2008.01.006
PubMed id: 18424341
Altmetrics provided by Altmetric